← Blog

Credential Landscape & Vendor Archive Series

Patricia Coughlin’s New Standard Intensive Short-Term Dynamic Psychotherapy (ISTDP), Trial Therapy, Coughlin Seminars, and the cloud AI scribe vendor archive: Trial Therapy written formulation narration without psychotherapist-patient privilege

October 8, 2026 · TherapyDraft · 5,900 words

1. Patricia Coughlin and the New Standard ISTDP model: institutional position and training organization

Patricia Coughlin is an independently practicing psychologist, ISTDP trainer, and author whose work has significantly shaped the dissemination of Intensive Short-Term Dynamic Psychotherapy in North America and internationally. Coughlin trained in the foundational ISTDP model developed by Habib Davanloo at McGill University — the pressure-and-challenge framework, the triangle of conflict, the triangle of person, and the systematic video-review training methodology that Davanloo pioneered — and subsequently developed what she characterizes as a refined and structured operationalization of the Davanloo approach, which she has taught under the designation “New Standard ISTDP” through workshops, intensives, and case consultation groups organized through Coughlin Seminars.

Coughlin’s principal textbooks are Intensive Short-Term Dynamic Psychotherapy: Theory and Technique (Coughlin Della Selva, 1996, Wiley) and Maximizing Effectiveness in Dynamic Psychotherapy (Coughlin, 2016, Routledge). The 1996 textbook presented a systematic elaboration of the Davanloo technique set in a teachable case-based format; the 2016 textbook refined and extended the model with additional attention to the structured assessment process, the Trial Therapy formulation, and the spectrum of psychopathology placement. She has also published Intensive Short-Term Dynamic Psychotherapy: Selected Papers of Patricia Coughlin (Coughlin, 2017, Karnac Books), a collection of papers on technique and clinical application. These publications are widely used in ISTDP training programs internationally.

What distinguishes Coughlin’s New Standard ISTDP from Davanloo’s original model — and from the ISTDP Institute’s training approach covered in post #175 of this series — is the degree of structural systematization Coughlin imposes on the initial assessment process. Davanloo’s approach to the initial evaluation is intensive and open-ended: the therapist conducts a pressure-and-challenge assessment across the first session, observing the patient’s anxiety pathways and defense activation in real time, and arriving at clinical judgments about the patient’s suitability and the appropriate technique approach through the lived experience of the session. Coughlin formalizes this assessment into a structured first session she designates the “Trial Therapy,” which is designed to produce specific documented findings organized around named clinical components: a written spectral placement, a written anxiety pathway identification, a written defense catalog, and a written unconscious therapeutic alliance quality rating. The Trial Therapy produces a formal written formulation document rather than a narrative summary of session impressions.

Coughlin Seminars — Patricia Coughlin’s training organization — offers workshops, intensives, and case consultation groups in the New Standard ISTDP model. The training model is distinguished by its heavy reliance on videotaped session review: Coughlin Seminars training typically requires practitioners to record their own clinical sessions and bring those recordings to supervision or case consultation, where the supervisor and group review specific moments of the video with annotated real-time feedback on technique decisions. This video-review training methodology — which Coughlin inherits from Davanloo, who pioneered the use of videotaped session review in ISTDP training — creates a distinct supervisory document type when those consultation sessions are conducted using cloud AI scribes, as analyzed in Section 6 below.

2. The credential landscape: Coughlin Seminars is not a health oversight agency; no governmental New Standard ISTDP certification exists

Coughlin Seminars is a private training and continuing education organization. It is not a state or federal government agency. It is not a credentialing body with mandatory membership requirements for practitioners using New Standard ISTDP techniques. It is not a professional association with board certification authority. It holds no regulatory power under HIPAA § 164.512(d) over practitioners who complete its training programs, and it maintains no authority over the cloud AI scribe vendor archives of independently practicing New Standard ISTDP-trained clinicians.

HIPAA § 164.512(d) permits a covered entity to disclose protected health information to a health oversight agency for authorized oversight activities, including audits, investigations, inspections, and licensure activities, without patient authorization. The provision applies to government agencies — programs administering Medicare and Medicaid, state agencies that license and certify health care providers and facilities, federal agencies conducting authorized health oversight activities — not to private training organizations. A private ISTDP training organization issuing certificates of workshop completion and case consultation participation has no health oversight authority under § 164.512(d), regardless of the clinical rigor of its training model or the sophistication of its practitioners.

There is no governmental board certification for New Standard ISTDP practitioners issued by any state or federal governmental body. There is no mandatory registry of New Standard ISTDP practitioners maintained by any governmental authority with § 164.512(d) jurisdiction. There is no mandatory Coughlin Seminars membership or certification requirement for practitioners implementing New Standard ISTDP techniques in clinical practice. A practitioner who has read Coughlin’s 2016 Routledge textbook and applies Trial Therapy assessment procedures and spectral formulation in their clinical work is a New Standard ISTDP practitioner in exactly the same sense as a practitioner who has completed the full Coughlin Seminars intensive training curriculum — without any credential gatekeeping, without any mandatory training registry, and without any governmental oversight mechanism governing the resulting clinical records.

Training in New Standard ISTDP is obtained through: Coughlin’s published textbooks (the 1996 Wiley textbook and the 2016 Routledge textbook present the model in sufficient detail for implementation without additional training); Coughlin Seminars workshops and intensives (continuing education events open to practitioners across licensure backgrounds, with no uniform requirement of qualifying state mental health licensure as an admission precondition); ISTDP Institute core training programs that incorporate Coughlin’s publications and teaching approach; graduate clinical training programs in psychodynamic clinical psychology and clinical social work that include Coughlin’s texts in their ISTDP curriculum; and case consultation groups organized by Coughlin-trained supervisors. The practitioner population includes licensed psychologists, licensed clinical social workers, licensed professional counselors, and licensed marriage and family therapists — but also pre-licensed trainees completing supervised hours, pastoral counselors, EAP counselors, and practitioners in training roles who do not yet hold qualifying independent state clinical mental health licensure.

For every practitioner without qualifying state clinical mental health licensure who implements New Standard ISTDP techniques — including Trial Therapy structured first sessions, spectral formulation, video recording for supervisory review, and case consultation group participation — the cloud AI scribe vendor archive of their sessions carries no psychotherapist-patient privilege protection. Psychotherapist-patient privilege is created by state mental health practice acts designating specific licensed professions whose practitioners carry privilege for sessions conducted within their licensed scope. Completion of Coughlin Seminars training does not create qualifying licensure. A Coughlin Seminars workshop certificate does not transform an unlicensed or pre-licensed practitioner’s session records into privileged clinical communications.

3. New Standard ISTDP Trial Therapy written formulation narration: the only vendor archive assessment document with named multi-component structural fields

The New Standard ISTDP Trial Therapy written formulation narration is the vendor archive record generated when a cloud AI scribe processes the session in which the Trial Therapy formulation is completed and dictated, or when a practitioner uses a cloud AI scribe to generate a session note from the Trial Therapy first session that includes the formulation document content. The Trial Therapy itself is a structured first session designed to function simultaneously as clinical assessment and treatment test: the practitioner applies ISTDP pressure and challenge while systematically observing the patient’s anxiety pathways, defense activation patterns, and response to therapeutic mobilization, with the goal of producing a formal written assessment of the patient’s suitability and recommended approach before proceeding to a full course of ISTDP treatment.

What distinguishes Coughlin’s Trial Therapy formulation from Davanloo’s initial assessment approach — and what creates the distinct vendor archive record type — is the formal document structure. The Trial Therapy formulation is not a narrative summary of session impressions; it is a structured written document with named clinical assessment components. Coughlin specifies the formulation as containing: (1) spectral placement, in which the practitioner places the patient on the fragile/borderline/neurotic character organization spectrum based on criteria assessed during the Trial Therapy; (2) anxiety pathway identification, in which the practitioner documents which of Davanloo’s three anxiety discharge pathways — striated muscle, smooth muscle, or cognitive-perceptual — is primary for this patient; (3) a defense catalog documenting the specific tactical and character defenses identified during the Trial Therapy session; (4) an unconscious therapeutic alliance (UTA) quality rating documenting Coughlin’s assessment of the quality and accessibility of the patient’s unconscious readiness to engage the therapeutic process (rated as high, moderate, poor, or absent); and (5) a treatment suitability recommendation and approach prescription derived from these findings, specifying what ISTDP technique modifications, if any, are indicated by the spectral placement and UTA quality.

The structural novelty of the Trial Therapy written formulation narration across the 261-post series requires careful comparison with the five Davanloo ISTDP record types covered in post #175. Post #175’s “defense analysis narration” documents the real-time identification and naming of defenses as they activate during a session — a session technique narration recording what the practitioner observed and labeled in the moment. The Trial Therapy formulation’s defense catalog is different: it is a structured written inventory of all the defenses identified across the full Trial Therapy session, organized as a formal clinical document component rather than as a session technique narration. The practitioner does not generate the defense catalog as a running session note of real-time observations; the practitioner produces it as a distinct named section of the Trial Therapy written formulation after the session, as a formal clinical assessment finding. The resulting vendor archive record is a multi-component written assessment document rather than a narration of what was done in the session.

Post #175’s “anxiety spectrum narration” documents real-time monitoring of which anxiety discharge pathway is active throughout a session — a moment-to-moment observation record. The Trial Therapy formulation’s “anxiety pathway identification” component is the formal assessment finding produced from that observation: not the running moment-to-moment record but the written clinical conclusion about which pathway is primary for this patient, documented as a named component of the Trial Therapy formulation document. Again, the structural distinction is between a session observation record and a formal written assessment finding organized as a named document component.

No prior record type in 261 posts documents a formal clinical assessment DOCUMENT — as opposed to a session NARRATION — with named structural component fields produced as the primary written output artifact of a first assessment session. Prior posts have covered initial assessment narrations, case formulation narrations, and initial evaluation records — but these are therapist-organized narrative records of the assessment session content, not formal multi-component written documents with named assessment fields analogous to the Trial Therapy formulation’s spectral placement, anxiety pathway, defense catalog, UTA quality, and treatment prescription components.

The Trial Therapy written formulation is also the document that determines the entire subsequent treatment approach. In New Standard ISTDP, the Trial Therapy formulation is not simply an intake note — it is the clinical specification for what the treatment will be. If the Trial Therapy formulation documents fragile-spectrum character organization and absent unconscious therapeutic alliance, the subsequent ISTDP approach is fundamentally different from what it would be for a neurotic-spectrum patient with high UTA quality. The formulation document thus generates a distinct and consequential vendor archive record: the contemporaneous formal written statement of the practitioner’s clinical assessment of the patient’s personality organization, treatment suitability, and recommended approach at the first session date.

4. New Standard ISTDP spectral character formulation and technique selection narration: fragile/borderline/neurotic character organization distinct from Davanloo’s anxiety discharge pathway spectrum

The New Standard ISTDP spectral character formulation and technique selection narration is the vendor archive record generated when a practitioner uses a cloud AI scribe to document the formal written assessment of the patient’s placement on Coughlin’s fragile/borderline/neurotic character organization spectrum and the specific technique selection decisions derived from that placement. The spectral character formulation is closely related to the Trial Therapy written formulation — the spectrum placement is the most consequential component of the Trial Therapy formulation document — but it generates a distinct record type because it produces not only a spectrum placement finding but a formal written technique prescription organized around that placement and documented across the treatment course as the patient’s known spectral status.

Coughlin’s spectrum of psychopathology organizes ISTDP patients into three levels of character organization. At the neurotic level, the patient demonstrates adequate ego adaptive capacity, healthy anxiety management in the striated muscle pathway, and a sufficient unconscious therapeutic alliance to tolerate pressure and challenge without ego destabilization. With neurotic-level patients, the practitioner can apply full ISTDP pressure-and-challenge technique relatively early in treatment without modification. At the borderline level, the patient demonstrates significant ego fragility in specific domains — a tendency toward smooth muscle or cognitive-perceptual anxiety discharge when pressure exceeds the therapeutic window, greater reliance on primitive defenses, and a less stable unconscious therapeutic alliance that requires more systematic development before intensive work. With borderline-level patients, the practitioner modifies the approach: more systematic anxiety regulation work, slower pacing of pressure, and more attention to stabilizing the UTA before attempting challenge sequences. At the fragile level, the patient demonstrates pervasive ego weakness — fragility across multiple domains, high risk of cognitive-perceptual anxiety discharge with limited pressure, and an absent or highly tenuous unconscious therapeutic alliance. With fragile-level patients, the approach requires substantial restructuring: psychoeducation about the anxiety pathways, active anxiety regulation work, and systemic stabilization before any pressure-and-challenge sequence can be safely applied.

The vendor archive record generated when a cloud AI scribe processes a New Standard ISTDP spectral formulation session documents: the specific clinical criteria the practitioner assessed to reach the spectrum placement finding (which anxiety pathway predominates, which defenses appeared, what the UTA quality indicators were, what the patient’s response to initial pressure revealed about ego adaptive capacity); the formal spectrum placement finding (fragile, borderline, or neurotic) as a clinical conclusion about the patient’s character organization; and the technique selection decisions derived from that placement — what ISTDP interventions will be used with this patient, in what sequence, with what modifications, and what the specific clinical rationale is for each modification based on the spectral placement.

The structural distinction from Davanloo’s “anxiety spectrum narration” (post #175) requires careful analysis because both records reference “spectra” in their names. The Davanloo anxiety spectrum narration documents real-time monitoring of which physiological anxiety discharge PATHWAY is active during a session — it is a within-session arousal monitoring record that helps the practitioner calibrate moment-to-moment technique decisions during a single session. It documents whether the patient’s anxiety is currently discharging through striated muscle (productive for processing), smooth muscle (requires reduction of pressure), or cognitive-perceptual (requires immediate intervention). This is fundamentally a physiological observation record measuring anxiety discharge in a specific session at a specific moment.

Coughlin’s spectral character formulation documents a formal assessment of the patient’s CHARACTER ORGANIZATION LEVEL — a standing psychological classification of the patient’s ego structure, defense organization, and capacity for intensive work that persists across the entire treatment course. Where the anxiety spectrum narration answers “which anxiety pathway is active right now in this session,” the spectral character formulation answers “what is this patient’s fundamental psychological organizational level, and what does that require of the treatment approach for the entire course of treatment.” The two spectra measure entirely different clinical variables, at entirely different timescales, with entirely different implications for clinical action.

The spectral character formulation also generates ongoing vendor archive records across the treatment course, not just at initial assessment. As ISTDP treatment proceeds, the spectral formulation may be revised — a patient initially placed at the borderline level may demonstrate neurotic-level capacities as the UTA strengthens and the anxiety pathway stabilizes — and the updated spectral formulation is documented as a revised clinical finding at the session date of the revision. The vendor archive thus contains a longitudinal spectral characterization record: the initial spectral placement at the Trial Therapy date, subsequent spectral assessment updates, and the cumulative treatment approach modifications derived from each spectral assessment across the treatment course.

5. New Standard ISTDP video recording consent and Coughlin Seminars supervisory use documentation narration: consent to named third-party training uses

The New Standard ISTDP video recording consent and Coughlin Seminars supervisory use documentation narration is the vendor archive record generated when a cloud AI scribe processes the session in which a Coughlin-trained practitioner obtains informed consent from the patient to have their sessions recorded for supervisory and training purposes under the Coughlin Seminars training model. Coughlin’s training model is distinguished by its heavy reliance on videotaped session review: practitioners bring recordings of their own clinical sessions to individual supervision or Coughlin Seminars case consultation groups, where the recordings are reviewed with annotated feedback on specific technique decisions. This training methodology requires a specific consent-to-record that names the supervisory and training uses to which the recording may be put.

The consent documentation session creates a vendor archive record with a specific structure. Standard informed consent to psychotherapy treatment is documented in a single consent form covering treatment purpose, limits of confidentiality, fees, and the practitioner’s credentials — a standard administrative document type that does not generate a distinct cloud AI scribe vendor archive session narration. The Coughlin Seminars video recording consent is a distinct consent layer: the patient is not simply consenting to treatment, but to having their sessions recorded on video and to having those recordings reviewed by (1) the practitioner in self-supervision, (2) the practitioner’s individual supervisor who is a Coughlin-trained clinician, and (3) a Coughlin Seminars case consultation group — a small group of practitioners and the group supervisor who review anonymized or identified recordings together as part of the training model. The consent document names these uses and may specify which uses are authorized (e.g., individual supervision only vs. group consultation review) and what identifying information will be concealed in group consultation settings.

When a cloud AI scribe processes the consent documentation session — the session in which the practitioner explains the recording uses to the patient, obtains the patient’s questions and responses, and documents the consent — the vendor archive records: the specific named supervisory and training uses the patient consented to; any limitations or conditions the patient imposed on the recording use (e.g., consent to individual supervision but not to group consultation, or consent to audio review but not to video review); the patient’s questions about the recording uses and the practitioner’s responses; and the specific date on which each consent was obtained. This consent documentation narration is a separately subpoenable vendor archive record: it is not the recording itself, but the record of the consent session in which the patient authorized (or limited) specific training uses of their recorded session content.

The structural novelty of the video recording consent and supervisory use documentation narration across the 261-post series requires comparison with prior consent documentation references. Prior posts in the series have covered specific consent-adjacent documentation: DBT-A’s “adolescent confidentiality fence documentation narration” (post #218) covered the specific documentation of the confidentiality parameters negotiated with adolescent patients and their parents; NET’s “testimony document narration” (post #214) covered the generation of an autobiographical narrative document with explicit consent for its use. Neither covers a consent documentation narration organized around consent to named third-party training organization uses of recorded session content. The Coughlin Seminars video consent is distinct because it creates a record of the patient’s authorization for a named external training organization (Coughlin Seminars) to have access to session content through the supervisory review process — a named third-party training organization use that does not appear in any prior post’s consent documentation record types.

The video recording consent narration also creates a privileged-versus-unprivileged record structure issue. When a practitioner without qualifying state clinical mental health licensure obtains Coughlin Seminars video recording consent from a patient, the consent documentation narration — the vendor archive record of the consent session itself — is not protected by any privilege. It is an unprivileged business record documenting an administrative event (the obtaining of consent for recording). But beyond the consent record itself, the video recording consent creates a chain of derivative non-privilege exposure: the recordings that the patient consented to having reviewed by the Coughlin Seminars consultation group are themselves not privileged when the treating practitioner lacks qualifying licensure, and the supervisory annotation records generated when those recordings are reviewed in the consultation group are also unprivileged — as analyzed in Section 6 below.

6. ISTDP supervisory video annotation and case consultation group session narration: supervisor’s contemporaneous knowledge of technique decisions

The ISTDP supervisory video annotation and case consultation group session narration is the vendor archive record generated when a Coughlin Seminars case consultation group session — or individual supervision session involving video review — is conducted using a cloud AI scribe. The consultation format involves a practitioner (the supervisee) presenting a recorded patient session to the group and supervisor for review; the supervisor and group watch the video and provide real-time annotated feedback on specific technique decisions at specific timestamps. If the consultation session is processed by a cloud AI scribe, the vendor archive records the supervisor’s and group’s contemporaneous technical assessments of the supervisee’s clinical choices.

This creates a distinct vendor archive record type with no prior analogue in the 261-post series. Every prior post in the series has documented SESSION records — records generated in the patient’s own therapy session, with the practitioner and the patient as the session participants. The ISTDP supervisory video annotation narration is a SUPERVISION record — generated in a supervision session in which the patient is not present but the patient’s session content is reviewed by a supervisor and a case consultation group. The vendor archive record documents: the specific patient session content that was reviewed (references to specific technique decisions, specific patient responses, specific clinical moments — all references to an identifiable patient’s session, even if the patient’s name is anonymized in the consultation setting); the supervisor’s contemporaneous technical characterizations of the supervisee’s choices at specific video timestamps; the group’s contemporaneous discussion of the clinical material; and any corrections, modeling of alternative approaches, or concerns identified by the supervisor in the review session.

The supervisory video annotation narration creates a distinct liability structure. It simultaneously documents two clinical actors whose records would not otherwise appear in the same vendor archive: the supervisee (whose technique decisions are analyzed) and the supervisor (whose professional assessments of those decisions are recorded). For the supervisee, the supervisory annotation narration becomes evidence of the contemporaneous professional characterization of their technique choices by a more senior clinician — characterizations that may bear directly on standard-of-care assessments in malpractice proceedings or licensing board investigations. For the supervisor, the annotation narration documents their contemporaneous knowledge of specific clinical events in the supervisee’s patient’s sessions at specific dates — knowledge that may establish supervisory notice of concerning practice patterns well before a complaint or adverse event occurs.

The supervisory annotation narration also creates an exposure that the original patient session record does not create in isolation: the supervisor’s professional vocabulary applied to the supervisee’s technique. When a Coughlin Seminars supervisor annotates a video review session and characterizes a supervisee’s technique decision as “applying pressure before the UTA was established,” “failing to address the smooth muscle anxiety signal before continuing challenge,” or “misreading the patient’s spectral level as neurotic when the fragility indicators were already present,” those characterizations — recorded in the cloud AI scribe vendor archive of the consultation session — are the supervisor’s own contemporaneous professional assessment of clinical errors in a specific patient’s treatment at a specific session date. If the supervisee is subsequently the subject of a malpractice claim alleging harm from inappropriate application of ISTDP pressure technique to a fragile-spectrum patient, the supervisory annotation narration from the case consultation group becomes a critical piece of evidence: it documents what the supervisor identified in the recorded sessions, whether the supervisor recognized the fragility indicators, what guidance the supervisor provided, and whether the supervisee’s continued application of pressure technique after that supervision session was against supervisory guidance.

The group consultation format adds additional exposure. Coughlin Seminars case consultation groups typically include multiple practitioners — five to twelve participants plus the group supervisor. When the group consultation session is processed by a cloud AI scribe, the vendor archive records the contemporaneous assessments of every group participant, not just the primary supervisor. Multiple practitioners’ professional characterizations of the supervisee’s clinical choices with an identifiable patient — even an anonymized patient, because the patient’s characteristics may make them identifiable from the clinical material — are captured in a single vendor archive record of the consultation session. Each of those practitioners is a potential subpoena target for their consultation session participation.

7. Five adversarial proceedings that reach the New Standard ISTDP vendor archive

Licensing board, ethics board, and standard-of-care proceedings

The Trial Therapy written formulation narration is the primary contemporaneous record of the practitioner’s clinical judgment at initial assessment in New Standard ISTDP. In licensing board proceedings examining whether a practitioner applied appropriate ISTDP technique — particularly proceedings involving complaints about intensive confrontational interventions with a patient whose spectral level may not have been adequately assessed — the Trial Therapy written formulation narration is the central evidentiary document. It captures: what spectral placement the practitioner assigned at the first session, what defense catalog was identified, what UTA quality was assessed, and what technique prescription was derived from those findings. A licensing board investigating a complaint that a practitioner applied pressure-and-challenge technique to a patient who was actually fragile-spectrum — and who decompensated in response — will seek the Trial Therapy formulation as the primary contemporaneous record of how the practitioner assessed the patient’s spectral level and what approach they planned as a result.

The supervisory video annotation narration adds a distinct dimension to licensing board proceedings. If the supervisee’s supervision records show that the case consultation group reviewed the sessions in question and identified spectral assessment concerns — or, alternatively, that the supervisor approved the technique approach — those contemporaneous supervisory assessments become central evidence in the licensing board’s standard-of-care analysis. The annotation record establishes both what the supervisee knew from supervision and what the supervisor’s contemporaneous assessment of the technique approach was. A supervisory annotation narration documenting that the supervisor reviewed the relevant sessions and characterized the technique as appropriate for the patient’s assessed spectral level is evidence supporting the supervisee’s standard-of-care defense. A supervisory annotation narration documenting the supervisor’s concern about smooth muscle anxiety signals being ignored constitutes evidence against the supervisee.

The video recording consent and supervisory use narration creates a related exposure in licensing board proceedings involving Coughlin Seminars consultation groups. A complaint that a patient’s clinical material was shared in a consultation group without adequate consent — or that the consent was not genuinely informed — requires access to the vendor archive record of the consent documentation session itself. The consent narration is the primary contemporaneous evidence of what the patient was told about the consultation group use, whether they understood and agreed, and what limitations (if any) they placed on the recording authorization.

Civil malpractice litigation

Civil malpractice litigation arising from New Standard ISTDP practice follows a predictable discovery pathway to four vendor archive records. The plaintiff’s counsel will seek the Trial Therapy written formulation narration as the primary standard-of-care record for the initial assessment and treatment selection decision — what did the practitioner document as the patient’s spectral level, and was the technique approach prescribed by that formulation appropriate? The spectral character formulation narrations across the treatment course will be sought as the contemporaneous record of any updates to the spectral assessment and any modifications to the technique approach. The supervisory annotation narrations from any Coughlin Seminars consultation review of the treatment sessions will be sought as evidence of what supervisory guidance the practitioner received. And any anxiety spectrum monitoring narrations — real-time records of smooth muscle or cognitive-perceptual anxiety pathway activation during pressure sequences — will be sought as contemporaneous evidence of whether the practitioner recognized anxiety signals indicating a need to modify technique and whether they acted on those signals.

The Trial Therapy written formulation is particularly consequential in malpractice cases involving patients who experienced adverse outcomes from intensive ISTDP technique. If the formulation documents a neurotic-spectrum placement and high UTA quality — and the patient subsequently experienced a destabilizing decompensation during pressure sequences — the malpractice claim will focus on whether the Trial Therapy formulation accurately assessed the patient’s spectral level and whether the prescribed technique approach was appropriate. The formulation is the contemporaneous professional document against which the practitioner’s subsequent technique decisions will be evaluated. If the formulation documents a borderline or fragile spectrum placement but the treatment records show that pressure-and-challenge sequences were applied without the modifications Coughlin specifies for those spectral levels, the formulation itself becomes evidence of the practitioner’s knowledge of the patient’s limitations and the gap between that knowledge and the technique actually employed.

Criminal proceedings

Criminal proceedings reach the New Standard ISTDP vendor archive through the same discovery pathway that reaches any psychotherapy session records when the treating practitioner lacks psychotherapist-patient privilege. The Trial Therapy written formulation narration contains high-affect verbatim clinical characterizations of the patient’s character organization — the defense catalog in particular documents the specific named defenses observed during high-affect mobilization in the Trial Therapy session, including the patient’s verbatim statements and responses during the pressure-and-challenge sequences. The defense catalog entry for a patient who disclosed charged-conduct-relevant material during the Trial Therapy’s pressure sequences is a contemporaneous clinical record of those disclosures, organized by the ISTDP framework’s defense taxonomy, accessible through criminal discovery without a privilege objection when the practitioner lacks qualifying licensure.

The spectral character formulation narration adds a specific criminal proceeding exposure: the formal clinical characterization of the patient’s character organization as fragile, borderline, or neurotic — with the specific clinical indicators documented for that classification — creates a vendor archive record of a diagnostic opinion about the patient’s psychological organization that may be sought in criminal proceedings where the defendant’s mental state is at issue. Unlike a formal DSM-based psychiatric evaluation, the spectral character formulation is produced in a psychotherapy context rather than a forensic evaluation context — but it contains contemporaneous professional assessments of the patient’s psychological organizational level, defense structure, and unconscious therapeutic alliance quality that have direct relevance to mental state assessments in criminal proceedings.

Family court and child custody proceedings

The spectral character formulation narration creates vendor archive records of particular sensitivity in family court and child custody proceedings. A formal clinical assessment documenting a named patient’s placement on the fragile, borderline, or neurotic character organization spectrum — with specific named defense catalog entries, specific UTA quality ratings, and technique prescriptions derived from those assessments — is one of the most clinically detailed personality organization assessments that appears in any of the 262 posts in this series. Where prior posts have covered formal assessment tools with clinical sensitivity in custody proceedings — the TLDP Cyclical Maladaptive Pattern formulation (post #256) naming specific persons in the four CMP categories, the Schema Therapy schema assessment (post #174) documenting named schema domains — the New Standard ISTDP spectral character formulation is a formal clinical document characterizing the patient’s overall psychological organizational level, their capacity for mature object relations, and the specific character defenses that organize their relational functioning.

In child custody proceedings where a parent’s psychological organization and parenting capacity are assessed, a Trial Therapy written formulation documenting borderline or fragile spectrum character organization with specific named defenses — projection, vagueness, intellectualization, affect isolation, somatization — and poor or absent UTA quality creates a contemporaneous clinical characterization directly relevant to parenting capacity evaluation. The formulation was not produced for forensic purposes; it was produced in a clinical assessment context. But it is a formal written document with named clinical assessment components that was processed by a cloud AI scribe vendor accessible through civil subpoena. A custody evaluator’s review of a subpoenaed Trial Therapy formulation narration provides access to a detailed contemporaneous clinical assessment of the parent’s character organization that no standard psychological testing protocol would have produced in the same form.

Supervisory liability proceedings in licensing complaints and malpractice

The supervisory video annotation and case consultation group session narration creates a distinct proceeding type with no prior analogue in the 261-post series: supervisory liability proceedings in which the supervisor’s contemporaneous knowledge of technique decisions and identified concerns becomes the central evidentiary issue. When a Coughlin-trained practitioner is the subject of a malpractice claim or licensing board complaint arising from New Standard ISTDP technique, the practitioner’s supervisor — whose contemporaneous assessments are documented in the consultation group annotation narrations — may be named as a co-defendant or a material witness. The supervisory annotation narrations from the case consultation group sessions in which the relevant patient’s sessions were reviewed are subpoenable through the cloud AI scribe vendor that processed those consultation sessions.

The supervisory annotation narrations in those consultation sessions are not protected by privilege because they were generated in a group consultation setting rather than in a confidential individual supervisory relationship — and because the primary clinical material discussed (the supervisee’s patient’s sessions) is itself not privileged when the supervisee lacks qualifying clinical licensure. The group consultation session record documents the supervisor’s contemporaneous professional assessments at specific consultation session dates, establishing precisely what the supervisor knew about the supervisee’s technique choices and when. If the supervisor identified clinical concerns but the supervisee continued the problematic technique approach, the annotation records establish the timeline of supervisory notice and the supervisee’s departure from supervisory guidance — evidentiary facts directly relevant to both the supervisee’s liability and the supervisor’s potential supervisory liability for failure to intervene.

On-device AI scribe processing eliminates the separately subpoenable vendor archive across all five proceedings. When a New Standard ISTDP practitioner processes all session notes — Trial Therapy formulation sessions, spectral formulation sessions, video recording consent sessions, and any note-taking during case consultation review — locally on device using on-device AI inference, no cloud AI vendor archive is created. There is no separately maintained third-party record for a subpoena to reach. The Trial Therapy written formulation narration exists only in the practitioner’s local clinical records, protected under the same privilege rules that govern those records. The supervisory annotation narration from the consultation group session is not separately accessible through a cloud AI vendor — it exists only in the local records of the consultation session participants. The chain of derivative exposure that begins with the cloud AI scribe’s independently maintained vendor archive — Trial Therapy formulation accessible in malpractice discovery, spectral formulation accessible in family court, supervisory annotation accessible in licensing board proceedings — does not exist when local inference replaces cloud processing across every session type.

Frequently asked questions